Delivery Order SPE2DB22D1106-SPE2DB25FEWJ3
Award Date
7/3/25
Potential Completion Date
7/7/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $2,420.16 and an ultimate completion date of July 2, 2025. It is a firm fixed-price contract, indicating the price is set and will not change. The contract is not designated as a set-aside, meaning it was open to all qualified...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $8,513.20 and a period of performance through June 24, 2025. The contract is designated as a firm-fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,905.84, is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and is a firm-fixed-price delivery order. There is no set-aside designation for this contract. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,768.44 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 150-200 MG TITRATION PK UU 28S, a pharmaceutical product, with a ceiling value of $1,004.40. The contract has a firm fixed price pricing type and an ultimate completion date of June 26, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication XCOPRI 200 MG TABLET 30S. The contract has a ceiling value of $1,767.72 and is a firm fixed-price delivery order, with a period of performance through May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XCOPRI 25 MG TABLET 30S. The contract has a firm fixed price of $1,768.44 and a performance period ending on June 6, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, to provide XCOPRI 100 MG tablets. The contract has a firm fixed price of $6,037.07 and a completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the drug XCOPRI 50 MG TABLET 30S. The contract has a ceiling value of $1,082.68 and a period of performance ending on July 2, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,178.96, is for the supply of the specialty medication XCOPRI 200 MG TABLET 30S. It is a firm fixed-price contract with a completion date of December 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...